PCMI
Princeton Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $8.38M | Buy |
131,433
+20,047
| +18% | +$1.28M | 4.24% | 5 |
|
|
2017
Q2 | $6.21M | Buy |
111,386
+21,768
| +24% | +$1.21M | 3.91% | 5 |
|
|
2017
Q1 | $4.87M | Buy |
89,618
+3,751
| +4% | +$204K | 3.08% | 15 |
|
|
2016
Q4 | $5.02M | Buy |
85,867
+4,140
| +5% | +$242K | 3.34% | 11 |
|
|
2016
Q3 | $4.41M | Buy |
81,727
+9,211
| +13% | +$497K | 2.88% | 15 |
|
|
2016
Q2 | $5.33M | Sell |
72,516
-4,091
| -5% | -$301K | 3.68% | 7 |
|
|
2016
Q1 | $4.89M | Buy |
76,607
+1,708
| +2% | +$109K | 3.4% | 7 |
|
|
2015
Q4 | $5.15M | Sell |
74,899
-30,893
| -29% | -$2.13M | 3.63% | 5 |
|
|
2015
Q3 | $6.26M | Sell |
105,792
-1,675
| -2% | -$99.2K | 3.79% | 5 |
|
|
2015
Q2 | $7.15M | Buy |
107,467
+650
| +0.6% | +$43.3K | 3.78% | 6 |
|
|
2015
Q1 | $6.89M | Buy |
106,817
+13,245
| +14% | +$854K | 3.53% | 8 |
|
|
2014
Q4 | $5.52M | Buy |
93,572
+16,775
| +22% | +$990K | 3.05% | 10 |
|
|
2014
Q3 | $3.93M | Buy |
76,797
+13,070
| +21% | +$669K | 2.51% | 15 |
|
|
2014
Q2 | $3.09M | Buy |
63,727
+9,305
| +17% | +$451K | 2.14% | 19 |
|
|
2014
Q1 | $2.83M | Buy |
54,422
+6,000
| +12% | +$312K | 2.05% | 19 |
|
|
2013
Q4 | $2.57M | Buy |
48,422
+4,770
| +11% | +$254K | 2.06% | 19 |
|
|
2013
Q3 | $2.02M | Buy |
43,652
+8,315
| +24% | +$385K | 1.85% | 23 |
|
|
2013
Q2 | $1.58M | Buy |
+35,337
| New | +$1.58M | 1.52% | 28 |
|